Cargando…
A case report of COVID-19 associated pulmonary mucormycosis
Hospitalized patients with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) are at risk for developing secondary fungal infections due to greater incidence of preexisting comorbidities and exposure to iatrogenic factors such as corticosteroid use. We present the case of a 44-year-old His...
Autores principales: | Khan, Nariman, Gutierrez, Christina G., Martinez, David Villafuerte, Proud, Kevin C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
UMF “Gr. T. Popa” Iasi Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565698/ https://www.ncbi.nlm.nih.gov/pubmed/34754927 http://dx.doi.org/10.22551/2020.28.0703.10172 |
Ejemplares similares
-
Pulmonary mucormycosis: A case report
por: Novais, António Grilo, et al.
Publicado: (2020) -
Immunosuppressants/Antifungals: COVID-19 associated mucormycosis, COVID-19 associated pulmonary aspergillosis and lack of efficacy: case report
Publicado: (2022) -
Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic
por: Mehta, Ravindra M, et al.
Publicado: (2022) -
Pulmonary pseudoaneurysm in the setting of concurrent COVID‐19 and pulmonary mucormycosis: A rare case report
por: Hamdar, Hussein, et al.
Publicado: (2023) -
COVID-19-associated disseminated mucormycosis: An autopsy case report
por: Kyuno, Daisuke, et al.
Publicado: (2022)